Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: MichBio News

MichBio Faces Many Challenges and Unknowns with New President, New Congress

Monday, February 27, 2017   (0 Comments)
Posted by: Stephen Rapundalo
Share |

It’s been a tumultuous start to 2017 on the national political front, to the say the least. Many Capitol Hill observers would agree that there hasn’t been a more unsettled time for policy politics than the present.

A new President is trying to find his footing amid broad polarization and discord across the country. There appears to be great difficulty in translating campaign rhetoric into legislative action. Moreover, a comprehensive vision and plan is lacking for moving forward on major issues like healthcare, immigration, trade, job creation, regulatory burdens, and much more.

A new Congress is feeling its way in dealing with an unpredictable and seemingly undisciplined Administration. It continues to seek unanimity unsuccessfully on key policy positions within partisan ranks, let alone between the parties. Legislatively, things appear to be happening quickly on some fronts, while others are moving at a snail’s pace. Most are all over the place as the ranks of federal bureaucracy remain depleted due to the slow pace of action by the Administration.

MichBio believes that we must stay focused if we are to make a difference during the current, disruptive federal transition – in other words, reinforcing our positions with current leaders and educating new officials in Congress and the Administration on the issues that matter most to Michigan’s bio-industry. Much of this advocacy effort will continue to be conducted in tandem with national industry groups.

It’s against this backdrop that MichBio begins its 2017 advocacy activities by participating in the AdvaMed Legislative Fly-In on February 28-March1 on Capitol Hill. It will be the first opportunity to interface directly with the current Michigan Congressional delegation. Visits with all offices have been arranged, especially with the freshmen legislators. The repeal of the medical device tax, medtech product coverage and payment policies, and reauthorization of the medical device user fee act (MDUFA) top the list of issues to be discussed. In addition, Fly-In attendees will meet separately with Rep. Eric Paulsen (MN), co-chair of the House MedTech Caucus, and key advisors in Vice President Pence’s office.

MichBio works regularly with Michigan’s Congressional Delegation and maintains a good relationship with members on both sides of the aisle. We’re hopeful that the new Congress can find resolution on a range of issues of concern to the state’s medtech sector. We offer to assist.
Follow MichBio on social media and e-mail. We will continue to give you suggestions for advocacy; please join us in speaking out and taking action.  

NOTE: Save the Date! Join us for the Michigan Biosciences Capitol Day on April 26, 2017 in Lansing.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal